EndoGastric Solutions is a medical technology company that develops incisionless transoral procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease and other GI disorders. It designs and manufactures EsophyX for use in endoluminal, transoral tissue approximation, thickness placation, and ligation in the GI tract. Its EsophyX is also indicated for the treatment of symptomatic chronic gastroesophageal reflux disease in patients who require and respond to pharmacological therapy.
|Employees (est.) (Oct 2019)||74||(+5%)|
EndoGastric Solutions total Funding
EndoGastric Solutions latest funding size
Time since last funding
|5 months ago|
EndoGastric Solutions investors
|Canaan Partners, Advanced Technology Ventures, Chicago Growth Partners, Radius Ventures, DeNovo Ventures, SightLine Partners, Accelmed, Flare Capital Partners, CRG, CRG L.P., Canepa Healthcare|
EndoGastric Solutions has 1.03k Twitter Followers. The number of followers has increased 0.9% month over month and increased 2.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was EndoGastric Solutions founded?
EndoGastric Solutions was founded in 2002.
Who are EndoGastric Solutions key executives?
EndoGastric Solutions's key executives are Skip Baldino, Michael Burke and Darren Crow.
How many employees does EndoGastric Solutions have?
EndoGastric Solutions has 74 employees.
Who are EndoGastric Solutions competitors?
Competitors of EndoGastric Solutions include RSP Systems, Bactiguard and CellAegis Devices.
Where is EndoGastric Solutions headquarters?
EndoGastric Solutions headquarters is located at 18109 NE 76th St #100, Redmond.
Where are EndoGastric Solutions offices?
EndoGastric Solutions has an office in Redmond.
How many offices does EndoGastric Solutions have?
EndoGastric Solutions has 1 office.
Receive alerts for 300+ data fields across thousands of companies